The U.S. Army has awarded PPD, Inc. (NASDAQ: PPDI) the U.S. Army Medical Research Acquisition Activity: Regulatory Affairs & Compliance Support contract to provide global regulatory and biostatistical services for several Army clinical development programs. It is a multiyear, indefinite delivery, indefinite quantity contract with a ceiling value of $45.5 million over a five-year period beginning April 15, 2011.
âThis contract enables us to deliver on our breadth of global regulatory and biostatistics services and assist the U.S. Army in advancing clinical programs that improve the health of men and women serving in our armed forces, â said Dr. Henrietta Ukwu, senior vice president of global regulatory affairs for PPD. âWe are pleased to partner with the U.S. Army in this effort and to continue to extend our long history of partnering with the U.S. government on clinical research and development.â
PPD has delivered global clinical support services to U.S. government research and development programs for 21 years.
